Global Client Base Wavelength Pharmaceuticals serves over 250 pharmaceutical manufacturers across more than 50 countries with a diversified portfolio of around 40 differentiated APIs and annual API production exceeding 250 metric tons, creating substantial cross-sell and expansion opportunities for new API programs and lifecycle support.

Regulatory Advantage The organization provides comprehensive technical and regulatory support throughout the product lifecycle, enabling faster time-to-market and a compelling selling point for clients needing multi-region regulatory strategies and ongoing compliance.

Complex Chemistry Deep expertise in complex chemistry, process development, scale-up, crystalline form control, and particle design enables high-value custom synthesis from pre-clinical scales to multi-ton commercial production.

Strategic Backing Backed by SK Capital with a history of strategic expansion through mergers, the CDMO has strong financial backing to fund capacity increases, new API programs, and global scale to support long-term development partnerships.

Resilient Supply Acquisition of Vanamali Organics and a focus on a robust supply chain signal reliability and risk mitigation, allowing discussions around dual-sourcing, faster lead times, and uninterrupted API supply for customers.